Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bausch Health Companies Inc. - SIC # 3851 - OPHTHALMIC GOODS
Ticker
Exchange
SIC #
Website
Latest Ticker
BHC
New York
3851
www.bauschhealth.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bausch Health Companies Inc.
Bausch Health's Xifaxan Patent Clarity, Policy Commentary in Focus for Q2, RBC Says
- Jul 15th, 2025 9:40 am
Bausch Health Companies (BHC) Canada Announces Expanded Availability of CABTREO Gel
- Jul 12th, 2025 12:47 pm
Chlamydia Market Analysis and Forecast, 2025-2035 Featuring ActivBiotics, Bausch Health, Allergan, WCG Clinical, Hologic, Evofem, CRMI, Meridian Bioscience, Pfizer
- Jul 11th, 2025 2:07 am
CORRECTING and REPLACING: Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Nova Scotia and Two Federal Programs
- Jul 10th, 2025 3:00 pm
Bausch Health Appoints New Chief Accounting Officer
- Jul 10th, 2025 2:15 pm
Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Quebec and Two Federal Programs
- Jul 9th, 2025 6:00 am
Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence
- Jul 7th, 2025 6:00 am
Bausch Health to Announce Second Quarter 2025 Results on July 30
- Jul 2nd, 2025 5:00 am
Marriott Vacations, Bausch Health See Activist Actions
- Jun 27th, 2025 5:03 pm
Barclays Cut Bausch & Lomb Target to $16, Keeping Rating Neutral in Early June
- Jun 23rd, 2025 9:58 am
A Billionaire Trump Supporter Is Buying These Two Stocks
- Jun 22nd, 2025 3:00 am
Bausch Health (BHC) Jumps 8.5% as Exec Hikes Stake; Subsidiaries Raise Over $3-Billion Fresh Funds
- Jun 14th, 2025 7:07 am
Bausch + Lomb Launching Senior Secured Notes Offering and Refinancing Credit Agreement
- Jun 10th, 2025 6:54 am
Why Is Bausch (BHC) Down 13% Since Last Earnings Report?
- May 30th, 2025 9:31 am
With 51% institutional ownership, Bausch Health Companies Inc. (NYSE:BHC) is a favorite amongst the big guns
- May 29th, 2025 4:33 am
Bausch + Lomb, Organon, Globalstar, Telephone and Data Systems, and nLIGHT Shares Skyrocket, What You Need To Know
- May 27th, 2025 10:47 am
3 Reasons to Avoid BLCO and 1 Stock to Buy Instead
- May 21st, 2025 10:00 pm
Bausch Health Announces 2025 Annual Meeting of Shareholder Results
- May 14th, 2025 2:15 pm
BLCO Q1 Earnings Call: Misses on Profit, Highlights Product Innovation and Tariff Uncertainty
- May 14th, 2025 4:36 am
New Strong Sell Stocks for May 13th
- May 13th, 2025 4:28 am
Scroll